Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/01/06/3213533/0/en/Sparrow-Pharmaceuticals-Announces-First-Patient-Enrolled-in-Phase-2b-Clinical-Trial-Evaluating-Clofutriben-for-Difficult-to-Control-Type-2-Diabetes.html

GLOBENEWSWIRE
06 Jan 2026

https://www.globenewswire.com/news-release/2025/09/24/3155451/0/en/Sparrow-Pharmaceuticals-Announces-95-Million-Series-B-Financing-to-Advance-Targeted-Therapy-for-Type-2-Diabetes.html

GLOBENEWSWIRE
24 Sep 2025

https://www.businesswire.com/news/home/20241211692841/en

BUSINESSWIRE
11 Dec 2024